Literature DB >> 1644913

Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.

W Debinski1, B Karlsson, L Lindholm, C B Siegall, M C Willingham, D FitzGerald, I Pastan.   

Abstract

Two immunotoxins were constructed by chemically coupling the monoclonal antibody C242 to Pseudomonas exotoxin A (PE) or a modified form, NlysPE40, that lacks the cell binding domain of PE. Monoclonal antibody C242 recognizes a specific sialylated carbohydrate epitope on a high molecular weight membrane glycoprotein present on cells of human colon, pancreatic, and cervical cancers. C242-PE and C242-NlysPE40 were very cytotoxic for cells expressing this antigen with 50% inhibition of protein synthesis occurring on Colo205 cells at 0.2 ng/ml (0.9 pM) for C242-PE and 6.0 ng/ml (31 pM) for C242-NlysPE40. The two immunotoxins also exhibited a strong antitumor effect on a human colon cancer xenograft grown in nude mice. The specificity and potency of these two C242 immunotoxins warrant their further development for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644913      PMCID: PMC443115          DOI: 10.1172/JCI115875

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  21 in total

1.  Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.

Authors:  C B Siegall; V K Chaudhary; D J FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

2.  Methyl 4-mercaptobutyrimidate as a cleavable cross-linking reagent and its application to the Escherichia coli 30S ribosome.

Authors:  R R Traut; A Bollen; T T Sun; J W Hershey; J Sundberg; L R Pierce
Journal:  Biochemistry       Date:  1973-08-14       Impact factor: 3.162

3.  Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.

Authors:  S J Kennel; R Falcioni; J W Wesley
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

4.  Disappearance of atrial natriuretic factor from circulation in the rat.

Authors:  K K Murthy; G Thibault; E L Schiffrin; R Garcia; L Chartier; J Gutkowska; J Genest; M Cantin
Journal:  Peptides       Date:  1986 Mar-Apr       Impact factor: 3.750

5.  Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice.

Authors:  L H Pai; D J FitzGerald; M Tepper; B Schacter; G Spitalny; I Pastan
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 13.312

6.  Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.

Authors:  L H Pai; J K Batra; D J FitzGerald; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 12.779

7.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

Authors:  V S Allured; R J Collier; S F Carroll; D B McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 12.779

8.  Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.

Authors:  T Kondo; D FitzGerald; V K Chaudhary; S Adhya; I Pastan
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.486

9.  Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

Authors:  J Hwang; D J Fitzgerald; S Adhya; I Pastan
Journal:  Cell       Date:  1987-01-16       Impact factor: 66.850

10.  Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.

Authors:  C Haglund; J Lindgren; P J Roberts; P Kuusela; S Nordling
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

View more
  7 in total

1.  Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.

Authors:  C Liu; B M Tadayoni; L A Bourret; K M Mattocks; S M Derr; W C Widdison; N L Kedersha; P D Ariniello; V S Goldmacher; J M Lambert; W A Blättler; R V Chari
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

2.  Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.

Authors:  J Wykosky; E Palma; D M Gibo; S Ringler; C P Turner; W Debinski
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

3.  β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1.

Authors:  Sazzad Hassan; Ashok Pullikuth; Kyle C Nelson; Anabel Flores; Yelena Karpova; Daniele Baiz; Sinan Zhu; Guangchao Sui; Yue Huang; Young A Choi; Ralph D'Agostino; Ashok Hemal; Urs von Holzen; Waldemar Debinski; George Kulik
Journal:  Mol Cancer Res       Date:  2020-09-14       Impact factor: 5.852

4.  Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.

Authors:  Daniele Baiz; Sazzad Hassan; Young A Choi; Anabel Flores; Yelena Karpova; Dana Yancey; Ashok Pullikuth; Guangchao Sui; Michel Sadelain; Waldemar Debinski; George Kulik
Journal:  Neoplasia       Date:  2013-10       Impact factor: 6.218

5.  The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.

Authors:  N R Hall; P J Finan; B M Stephenson; D A Purves; E H Cooper
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

6.  Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies.

Authors:  Gadi Cohen; Shimon Lecht; Mor Oron-Herman; Tatjana Momic; Aviram Nissan; Philip Lazarovici
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

Review 7.  Recombinant immunotoxins.

Authors:  I Pastan; L H Pai; U Brinkmann; D FitzGerald
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.